The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in the vaccine. The company was formerly known as Double Helix Corporation.
Market Cap | 1.466 Billion | Shares Outstanding | 127.687 Million | Avg 30-day Volume | 1.22 Million |
P/E Ratio | 5.3246 | Dividend Yield | 0.0 | EPS | 1.87 |
Price to Revenue | 1.9141 | Debt to Equity | 0.3935 | EBITDA | 221.637 Million |
Price to Book Value | 2.2261 | Operating Margin | 33.9392 | Enterprise Value | 824.804 Million |
Current Ratio | 9.071 | EPS Growth | 1 | Quick Ratio | 8.27 |
1 Yr BETA | 1.288 | 52-week High/Low | 17.48 / 9.42 | Profit Margin | 35.9913 |
Operating Cash Flow Growth | -43.0159 | Altman Z-Score | 2.8315 | Free Cash Flow to Firm | 92.257 Million |
Earnings Report | 2023-08-03 |
Please sign in first
none
1 Million total shares from 2 transactions
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
|
12,214 | 2023-05-26 | 1 | |
|
31,548 | 2023-05-26 | 2 | |
|
20,089 | 2023-05-26 | 1 | |
|
38,447 | 2023-05-26 | 1 | |
|
10,714 | 2023-05-26 | 1 | |
|
2,925,714 | 2023-05-26 | 4 | |
|
18,750 | 2023-05-26 | 1 | |
|
10,714 | 2023-05-26 | 1 | |
|
13,714 | 2023-05-26 | 1 | |
NOVACK DAVID F PRESIDENT & COO |
|
3,187 | 2023-05-04 | 7 |
JANSSEN ROBERT SVP AND CMO |
|
49,925 | 2023-02-27 | 5 |
SPENCER RYAN CEO AND DIRECTOR |
|
178,459 | 2023-02-27 | 4 |
MACDONALD KELLY SVP AND CFO |
|
2,359 | 2023-02-27 | 2 |
BURGESS JUSTIN CHIEF ACCOUNTING OFFICER |
|
0 | 2023-02-27 | 3 |
|
27,857 | 2022-05-26 | 0 | |
OSTRACH MICHAEL S SENIOR VICE PRESIDENT |
|
0 | 2021-02-03 | 0 |
|
0 | 2020-05-28 | 0 | |
JOHNSON DAVID LOUIS VICE PRESIDENT |
|
48,380 | 2020-03-13 | 0 |
COFFMAN ROBERT SENIOR VICE PRESIDENT |
|
77,768 | 2019-06-02 | 0 |
GRAY EDDIE CEO AND DIRECTOR |
|
304,597 | 2019-06-02 | 0 |
|
0 | 2019-05-30 | 0 | |
|
0 | 2019-05-30 | 0 | |
|
0 | 2017-06-02 | 0 | |
|
0 | 2014-05-28 | 0 | |
|
0 | 2014-05-28 | 0 | |
TUCK STEPHEN F VP, GLOBAL TECHNICAL OPS |
|
0 | 2013-02-05 | 0 |
LEW JENNIFER VP, FINANCE & PAO |
|
0 | 2013-02-05 | 0 |
MARTIN J TYLER PRESIDENT, CMO & DIRECTOR |
|
222,089 | 2012-11-16 | 0 |
|
3,031,431 | 2012-10-16 | 0 | |
LARSON CHRISTINE R VP AND CHIEF FINANCIAL OFFICER |
|
0 | 2012-08-13 | 0 |
JANOWICZ ZBIGNIEW CEO DYNAVAX EUROPE |
|
0 | 2012-03-09 | 0 |
|
0 | 2010-05-12 | 0 | |
|
0 | 2010-05-12 | 0 | |
SYMPHONY CAPITAL GP, L.P. SYMPHONY GP, LLC SYMPHONY STRATEGIC PARTNERS LLC |
|
9,031,431 | 2010-04-16 | 0 |
|
17,115,404 | 2009-09-10 | 0 | |
|
25,254,628 | 2009-06-03 | 0 | |
SMELTZER DEBORAH A VP, OPERATIONS & CFO |
|
0 | 2009-03-10 | 0 |
DEERFIELD SPECIAL SITUATIONS FUND, L.P. DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LTD |
|
No longer subject to file | 2008-10-22 | 0 |
SANDERS MARTIN E EVP AND CDO |
|
0 | 2008-10-03 | 0 |
DEERFIELD SPECIAL SITUATIONS FUND, L.P. |
|
1,250,000 | 2007-07-18 | 0 |
|
0 | 2007-07-18 | 0 | |
|
0 | 2007-07-18 | 0 | |
HENN TIMOTHY G VP, FINANCE & ADMINISTRATION |
|
20,000 | 2007-02-02 | 0 |
VAN NEST GARY A VP, PRECLINICAL RESEARCH |
|
25,000 | 2007-02-02 | 0 |
|
10,030 | 2006-11-14 | 0 | |
|
4,851,538 | 2006-10-04 | 0 | |
|
10,000 | 2006-06-14 | 0 | |
|
328,447 | 2006-05-15 | 0 | |
LEVITT DANIEL J VICE PRESIDENT |
|
50,000 | 2006-02-14 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-05-31 17:30:22 -0400 | 2023-05-26 | A | 5,357 | a | 13,714 | direct | ||||||||||
2023-05-31 17:43:23 -0400 | 2023-05-26 | A | 22,500 | a | 22,500 | direct | ||||||||||
2023-05-31 17:43:23 -0400 | 2023-05-26 | A | 5,357 | a | 10,714 | direct | ||||||||||
2023-05-31 17:35:33 -0400 | 2023-05-26 | A | 22,500 | a | 22,500 | direct | ||||||||||
2023-05-31 17:35:33 -0400 | 2023-05-26 | A | 5,357 | a | 20,089 | direct | ||||||||||
2023-05-31 17:34:51 -0400 | 2023-05-26 | A | 22,500 | a | 22,500 | direct | ||||||||||
2023-05-31 17:34:51 -0400 | 2023-05-26 | A | 5,357 | a | 18,750 | direct | ||||||||||
2023-05-31 17:34:02 -0400 | 2023-05-26 | A | 22,500 | a | 22,500 | direct | ||||||||||
2023-05-31 17:34:02 -0400 | 2023-05-26 | A | 5,357 | a | 38,447 | direct | ||||||||||
2023-05-31 17:30:22 -0400 | 2023-05-26 | A | 22,500 | a | 22,500 | direct | ||||||||||
2023-05-31 17:26:42 -0400 | 2023-05-26 | A | 22,500 | a | 22,500 | direct | ||||||||||
2023-05-31 17:26:42 -0400 | 2023-05-26 | A | 5,357 | a | 10,714 | direct | ||||||||||
2023-05-31 17:23:48 -0400 | 2023-05-26 | A | 22,500 | a | 22,500 | direct | ||||||||||
2023-05-31 17:23:48 -0400 | 2023-05-26 | A | 5,357 | a | 10,714 | direct | ||||||||||
2023-05-31 17:25:19 -0400 | 2023-05-26 | A | 22,500 | a | 22,500 | direct | ||||||||||
2023-05-31 17:25:19 -0400 | 2023-05-26 | A | 5,357 | a | 12,214 | direct | ||||||||||
2023-05-31 17:20:32 -0400 | 2023-05-26 | A | 22,500 | a | 22,500 | direct | ||||||||||
2023-05-31 17:20:32 -0400 | 2023-05-26 | A | 5,357 | a | 31,548 | direct | ||||||||||
HACK ANDREW A. F. - Director see footnotes |
2023-05-19 16:30:37 -0400 | 2023-05-18 | S | 1,000,000 | $10.55 | d | 2,915,000 | indirect | 0.8189 | 2.1838 | 2.2748 | 3 | 0.0 | 1 | ||
2023-05-05 20:58:23 -0400 | 2023-05-04 | S | 17,515 | $10.90 | d | 3,187 | direct | -1.0999 | 5.0412 | 5.0412 | 6 | -1.0999 | 2 |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
DYNAVAX TECHNOLOGIES CORP DVAX | 2023-06-01 22:15:04 UTC | 4.7657 | 0.3043 | 1800000 |
DYNAVAX TECHNOLOGIES CORP DVAX | 2023-06-01 21:45:04 UTC | 4.7657 | 0.3043 | 1800000 |
DYNAVAX TECHNOLOGIES CORP DVAX | 2023-06-01 21:15:05 UTC | 4.7657 | 0.3043 | 1800000 |
DYNAVAX TECHNOLOGIES CORP DVAX | 2023-06-01 20:45:03 UTC | 4.7657 | 0.3043 | 1800000 |
DYNAVAX TECHNOLOGIES CORP DVAX | 2023-06-01 20:15:04 UTC | 4.7785 | 0.2915 | 1800000 |
DYNAVAX TECHNOLOGIES CORP DVAX | 2023-06-01 19:45:03 UTC | 4.7785 | 0.2915 | 1800000 |
DYNAVAX TECHNOLOGIES CORP DVAX | 2023-06-01 19:15:04 UTC | 4.7785 | 0.2915 | 1800000 |
DYNAVAX TECHNOLOGIES CORP DVAX | 2023-06-01 18:45:03 UTC | 4.7823 | 0.2877 | 1800000 |
DYNAVAX TECHNOLOGIES CORP DVAX | 2023-06-01 18:15:04 UTC | 4.7823 | 0.2877 | 1800000 |
DYNAVAX TECHNOLOGIES CORP DVAX | 2023-06-01 17:45:04 UTC | 4.7823 | 0.2877 | 1800000 |
DYNAVAX TECHNOLOGIES CORP DVAX | 2023-06-01 17:15:04 UTC | 4.7823 | 0.2877 | 1800000 |
DYNAVAX TECHNOLOGIES CORP DVAX | 2023-06-01 16:45:04 UTC | 4.7705 | 0.2895 | 1800000 |
DYNAVAX TECHNOLOGIES CORP DVAX | 2023-06-01 16:15:04 UTC | 4.7705 | 0.2895 | 1800000 |
DYNAVAX TECHNOLOGIES CORP DVAX | 2023-06-01 15:45:03 UTC | 4.7705 | 0.2895 | 1800000 |
DYNAVAX TECHNOLOGIES CORP DVAX | 2023-06-01 15:15:04 UTC | 4.7705 | 0.2895 | 1800000 |
DYNAVAX TECHNOLOGIES CORP DVAX | 2023-06-01 14:45:04 UTC | 4.7705 | 0.2895 | 1800000 |
DYNAVAX TECHNOLOGIES CORP DVAX | 2023-06-01 14:15:04 UTC | 4.7705 | 0.2895 | 1800000 |
DYNAVAX TECHNOLOGIES CORP DVAX | 2023-06-01 13:45:04 UTC | 4.7997 | 0.2603 | 1800000 |
DYNAVAX TECHNOLOGIES CORP DVAX | 2023-06-01 13:15:04 UTC | 4.7997 | 0.2603 | 1800000 |
DYNAVAX TECHNOLOGIES CORP DVAX | 2023-06-01 12:45:04 UTC | 4.7997 | 0.2603 | 1800000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
Franklin Alternative Strategies Funds- K2 Alternative Strategies Fund | DVAX | -80095.0 shares, $-824978.5 | 2023-02-28 | N-PORT |
JNL Series Trust- JNL Multi-Manager Alternative Fund | DVAX | -190984.0 shares, $-1873553.04 | 2023-03-31 | N-PORT |
LAZARD FUNDS INC- Lazard Enhanced Opportunities Portfolio | DVAX | -639.0 shares, $-6268.59 | 2023-03-31 | N-PORT |